,
“Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials”, PLoS ONE, vol. 3, p. e2043, 2008.
, “A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials”, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
“Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, , “Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya”, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
, “Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate”, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
,